Valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant recipients: a single-center experience

被引:0
|
作者
Takaya Iida
Kenichiro Miura
Hideki Ban
Taro Ando
Yoko Shirai
Sho Ishiwa
Atsutoshi Shiratori
Naoto Kaneko
Tomoo Yabuuchi
Kiyonobu Ishizuka
Masanori Takaiwa
Kazuhide Suyama
Masataka Hisano
Motoshi Hattori
机构
[1] Tokyo Women’s Medical University,Department of Pediatric Nephrology
[2] Matsuyama Red Cross Hospital,Department of Pediatrics
[3] Fukushima Medical University,Department of Pediatrics
[4] Chiba Children’s Hospital,Department of Nephrology
来源
关键词
Cytomegalovirus infection; Valganciclovir; Prophylaxis; Pediatric kidney transplantation; Adverse event;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:531 / 536
页数:5
相关论文
共 50 条
  • [21] Cytomegalovirus Disease in Renal Transplant Recipients: A Single-Center Experience
    Bhadauria, Dharmendra
    Sharma, R. K.
    Kaul, A.
    Prasad, Narayan
    Gupta, Amit
    Gupta, Anurag
    Srivastava, Aneesh
    INDIAN JOURNAL OF MICROBIOLOGY, 2012, 52 (03) : 510 - 515
  • [22] Parvovirus in Kidney Transplant Recipients: A Single-Center Experience
    Tambi, Priyash
    Dave, Ruchir
    Kute, Vivek
    Patel, Himanshu, V
    Shah, Shivam
    Yadav, Rahul
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2023, 21 (11) : 868 - 871
  • [23] Valganciclovir for cytomegalovirus prophylaxis in liver transplant recipients
    Park, Jeong M.
    Lake, Kathleen D.
    Fontana, Robert J.
    LIVER TRANSPLANTATION, 2006, 12 (06) : 1022 - 1023
  • [24] Nosocomial infection in kidney transplant recipients: A retrospective analysis of a single-center experience
    Ferraresso, M
    Berardinelli, L
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (06) : 2495 - 2496
  • [25] BK Virus Infection in Thai Kidney Transplant Recipients: A Single-Center Experience
    Skulratanasak, P.
    Mahamongkhonsawata, J.
    Chayakulkeereeb, M.
    Larpparisutha, N.
    Premasathiana, N.
    Vongwiwatana, A.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (04) : 1077 - 1079
  • [26] Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis
    Paulsen, Grant
    Cumagun, Pia
    Mixon, Emily
    Fowler, Karen
    Feig, Daniel
    Shimamura, Masako
    PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [27] Characteristics and Outcomes of Cytomegalovirus Infection in Seropositive Kidney Transplant Recipients in the Era of Antiviral Prophylaxis with Valacyclovir: A Single-Center Study in Morocco
    Rezzouk, Bouchra
    Bouattar, Tarik
    Belkadi, Bouchra
    Razine, Rachid
    Bayahia, Rabia
    Ouzeddoun, Naima
    Benamar, Loubna
    Rhou, Hakima
    Bouihat, Najat
    Ibrahimi, Azeddine
    Seffar, Myriam
    Kabbaj, Hakima
    TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2021, 13 : 1 - 12
  • [28] Cytomegalovirus infection in high-risk kidney transplant recipients receiving thymoglobulin induction-a single-center experience
    Puttarajappa, Chethan
    Bhattarai, Manoj
    Mour, Girish
    Shen, Chengli
    Sood, Puneet
    Mehta, Rajil
    Shah, Nirav
    Tevar, Amit D.
    Humar, Abhinav
    Wu, Christine
    Hariharan, Sundaram
    CLINICAL TRANSPLANTATION, 2016, 30 (09) : 1159 - 1164
  • [29] Long-term outcome of pediatric kidney transplant recipients: A single-center experience
    Obeid, Dalia
    Alaiya, Ayodele
    Aldhafiry, Rezgah
    Almaiman, Weiam
    Karar, Enaam
    Alrddadi, Sulaiman
    Alhasan, Khalid
    Tariq, Ali
    Broering, Dieter
    Almojalli, Hamad
    TRANSPLANTATION, 2024, 108 (09) : 31 - 31
  • [30] Twice Weekly Valganciclovir for Cytomegalovirus Infection Prophylaxis in Kidney Transplant Recipients with Delayed Graft Function on Hemodialysis
    Mehta, S. A.
    Katz, A.
    Dieter, R.
    Jen, P.
    Siegfried, J.
    Papadopoulos, J.
    Lewis, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 784 - 784